The market implication is not the quarter itself, but the reset in forward earning power: if the higher-yield mix is sustainable, IFS moves from a “beat-and-return-to-normal” story to a structurally higher ROE compounder. That matters because a high-teens ROE in a low-growth banking market usually deserves a valuation re-rate versus domestic peers, especially if fee income is becoming less rate-dependent and more operating-leverage driven.

Second-order, the bullish setup is strongest if this is share gain rather than temporary spread capture. Higher-yield lending tends to force weaker competitors to choose between margin defense and growth, which can pressure smaller Peru-focused lenders and eventually pull deposit pricing up across the system. The risk is that the same loan categories driving upside today are often the first to show credit-cost slippage 2-3 quarters later, so the earnings trajectory is more fragile than the headline print suggests.

For the next 1-3 months, the trade is about estimate revisions and whether consensus migrates toward the new earnings run-rate; if that happens, the stock can rerate before any macro data matters. Over 6-18 months, the key question is whether ROE stays above cost of equity through a slower credit cycle; if not, the multiple expansion should fade quickly. The contrarian view is that the market may be underestimating how much of this is bank-specific execution versus a broad Peru financials beta move, creating room for relative outperformance if the franchise keeps taking share.